Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
6,102
+1,112
+22% +$49.7K 0.01% 847
2026
Q1
$240K Sell
4,990
-2,896
-37% -$135K 0.01% 818
2025
Q4
$382K Sell
7,886
-1,043
-12% -$51.7K 0.02% 657
2025
Q3
$421K Buy
8,929
+2,424
+37% +$117K 0.02% 554
2025
Q2
$314K Sell
6,505
-212
-3% -$10.8K 0.02% 529
2025
Q1
$373K Buy
6,717
+1,101
+20% +$59.6K 0.03% 367
2024
Q4
$271K Sell
5,616
-52
-0.9% -$2.64K 0.02% 431
2024
Q3
$327K Sell
5,668
-82
-1% -$4.43K 0.03% 347
2024
Q2
$279K Sell
5,750
-211
-4% -$10.2K 0.03% 368
2024
Q1
$290K Buy
+5,961
New +$291K 0.03% 369
2023
Q4
Sell
-34,305
Closed -$1.84M 462
2023
Q3
$1.84M Buy
+34,305
New +$1.83M 0.23% 67

Other funds holding SNY

Syon Capital's SNY Position: Q2 2026 in Review

Syon Capital increased its Sanofi (SNY) stake by 22% in Q2 2026, buying an estimated $49.7K and bringing the position to 6,102 shares worth $260K. The position accounts for 0.01% of the portfolio, ranked #847.

Syon Capital first reported a position in SNY in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.84M in Q3 2023. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Syon Capital held 6,102 shares of Sanofi worth $260K as of Q2 2026.
  • Syon Capital bought 1,112 Sanofi shares in Q2 2026, an estimated $49.7K.
  • Sanofi made up 0.01% of Syon Capital's portfolio in Q2 2026, its #847 holding.
  • Syon Capital first reported a position in Sanofi in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's Sanofi position peaked at $1.84M in Q3 2023.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.